The largest database of trusted experimental protocols

Vivaspin 20 ultrafiltration unit

Manufactured by Sartorius
Sourced in Germany

The Vivaspin 20 Ultrafiltration Units are laboratory equipment designed for the concentration and purification of macromolecules, such as proteins, through the process of ultrafiltration. The units feature a centrifugal ultrafiltration membrane that allows the selective retention of molecules above a specific molecular weight cutoff, while allowing smaller molecules and solvents to pass through. The Vivaspin 20 provides a convenient and efficient way to concentrate and purify sample volumes up to 20 milliliters.

Automatically generated - may contain errors

10 protocols using vivaspin 20 ultrafiltration unit

1

Purification of SARS-CoV-2 Spike Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
After filtration through 0.45 μm membrane filters (Merck Millipore, Germany), supernatants containing RBD or soluble Spike were concentrated and diafiltrated against 20 mM sodium phosphate buffer containing 500 mM NaCl and 20 mM imidazole (pH 7.4) using a Labscale TFF system equipped with a 5 kDa cut-off Pellicon XL device (Merck Millipore). The His-tagged proteins were captured using a 5 mL HisTrap FF crude column connected to an ÄKTA pure chromatography system (both from Cytiva, United States). Bound proteins were eluted by applying a linear gradient of 20–500 mM imidazole over 20 column volumes. ACE2-Fc variants were purified by affinity chromatography using a 5 mL HiTrap Protein A column (Cytiva) according to the manufacturer’s instructions and 0.1 M glycine-HCl (pH 3.5) for elution. Eluate fractions were immediately neutralized using 2 M Tris (pH 12.0). Fractions containing the protein of interest were pooled, concentrated using Vivaspin 20 Ultrafiltration Units (Sartorius, Germany) and dialyzed against PBS (pH 7.4) at 4 °C overnight using SnakeSkin Dialysis Tubing (Thermo Fisher Scientific). The RBD was further purified by size exclusion chromatography (SEC) using a HiLoad 16/600 Superdex 200 pg column (Cytiva) eluted with PBS. All purified proteins were stored at –80 °C until further use.
+ Open protocol
+ Expand
2

Evaluating Echinaforce's Antiviral Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
4 × 104 TCID50/ml HCoV-229E were incubated with Echinaforce diluted to 0, 2, 5, 10, 20, 40, 500 and 100 μg/ml in 2%-FBS-DMEM and incubated for 1 h at room temperature (RT) on a rocking platform. To estimate residual infectivity, treated virus dilutions were washed four times with 15–17 ml wash buffer (1:100 PBS, pH 7.4, in dH2O, Biochrom, Germany) and filtered through Vivaspin® 20 Ultrafiltration Units (Sartorius AG, Goettingen Germany) at 800 g for 15 min. Viruses were recovered from the Ultrafiltration Unit with glycine buffer (3750 mg/l glycine, 10 g/l beef extract, 14.6 g/l NaCl, pH 9.5, Sigma-Aldrich, Germany), and diluted in 1:10 in 5%-FBS -DMEM. Residual virus infectivity was determined by a limiting dilution assay (TCID50) according to Spearman-Karber [27 (link)].
+ Open protocol
+ Expand
3

Purification of SARS-CoV-2 Spike Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For purification, the supernatants were filtered through 0.45 μm membrane filters (Merck Millipore HAWP04700), concentrated and diafiltrated against 20 mM phosphate buffer containing 500 mM NaCl and 20 mM imidazole (pH 7.4) using a Labscale TFF system equipped with a 5 kDa cut‐off PelliconTM XL device (Merck Millipore, PXC005C50). His‐tagged trimer Spike and monomeric RBD were captured using a 5 ml HisTrap FF crude column (Cytiva, 17528601) connected to an ÄKTA pure chromatography system (Cytiva). Bound proteins were eluted by applying a linear gradient of 20–500 mM imidazole over 20 column volumes. Fractions containing the protein of interest were pooled, concentrated using Vivaspin 20 Ultrafiltration Units (Sartorius, VS2011) and dialyzed against PBS (pH 7.4) at 4°C overnight using a SnakeSkin Dialysis Tubing (Thermo Fisher Scientific, 68100). The RBD was further polished by size exclusion chromatography (SEC) using a HiLoad 16/600 Superdex 200 pg column (Cytiva, 28‐9893‐35) equilibrated with PBS (pH 7.4). Both purified proteins were stored at −80°C until further use.
+ Open protocol
+ Expand
4

Polymersome Fabrication and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
PMOXA15-PDMS68-PMOXA15 was solubilized in ethanol (99.8 %) to obtain a 20 % w/v polymer solution. The polymer solution was added to deionized water in a 1:20 ratio to obtain a 1 % w/v polymersome dispersion and stirred in 12 mL-stirred tank reactors at 4000 rpm with an S-type stirrer for 1.25 h according to the method of Poschenrieder et al. [40 ]. The polydispersity index, the intensity-based diameter (z-average) and the number-based mean diameter (dP) of the polymersomes were measured via dynamic light scattering on a ZetaSizer Nano-S (Malvern Instruments, Malvern, UK). For each polymersome preparation, the polydispersity index was ≤0.2 with a z-average of approximately 185 nm in a narrow, monomodal size distribution and a dP of 110 nm. The average aggregation number has been determined to 43,000 polymer chains per polymersome [40 ]. Polymersome concentrations above 1 % w/v were obtained by concentrating the polymersome dispersion in 10 kDa Vivaspin 20 ultrafiltration units (Sartorius, Göttingen, Germany).
+ Open protocol
+ Expand
5

Purification of CD81-GFP Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable cells expressing CD81-GFP (CHO) or CD81-GFP (Hu) were cultivated under batch culture conditions in 250 ml Erlenmeyer flasks.
Cultures were terminated on day 5 and the conditioned medium was harvested. Cell culture supernatant was collected by 500 × g centrifugation and then passed through 0.2 µm filters (Steriflip, Merck Millipore). 20 ml of the resulting clarified conditioned medium (CCM)
was processed with 300 kDa Vivaspin 20 Ultrafiltration Units (Sartorius) according to manufacturer's protocol and retentates were concentrated to approximately 0.5 ml. Size exclusion chromatography (SEC) was performed using qEV original/35 nm (Izon Science) columns according to the manufacturer's protocol. Briefly, 0.4 ml of ultrafiltration retentate was loaded onto the columns and 0.5 ml fractions were manually collected over a total elution run of 12 ml using PBS (10 mM, pH 7.4) as the buffer. Total protein was quantified with the Micro BCA Protein Assay Kit (Cat. 23235, Thermo Scientific) according to manufacturer's instructions.
+ Open protocol
+ Expand
6

Recombinant Protein Purification from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effector or accessory protein expression construct was transformed into an E. coli T7 expression strain, NiCo21(DE3) (New England Biolabs) and grown as described in the Experimental Models and Subject Details section of the STAR methods. The cells were harvested by centrifugation and cell paste was resuspended in 80 ml of freshly prepared Lysis Buffer (50 mM Hepes pH 7.6, 0.5M NaCl, 10 mM imidazole, 14 mM 2-mercaptoethanol and 5% glycerol) supplemented with protease inhibitors (cOmplete, EDTA-free, Roche Diagnostics Corporation). The resuspended cells were broken by passing through a cell disruptor (Constant System Limited). Lysate was cleared by centrifugation twice at 28,000g for 30 min each. The clarified lysate was applied to a 5 ml HisTrap FF chromatography column (GE Life Sciences). Protein purification was performed via FPLC (AKTA Pure, GE Healthcare Life Sciences). After washing with Lysis Buffer, protein was eluted with a gradient of 10 mM to 250 mM of imidazole. Fractions containing protein of the expected size were pooled, concentrated in Vivaspin 20 ultrafiltration unit (Sartorius) and either used directly for biochemical assays or frozen at −80°C for storage. Protein purity was determined by SDS-PAGE analysis and protein concentration was determined by Qubit protein assay kit (Thermo Fisher).
+ Open protocol
+ Expand
7

Transient Expression and Purification of hPLD3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type HEK 293T cells were cotransfected with both the vector containing the desired hPLD3-sequence and the pCMV(CAT)T7-SB100(AL) vector (Dr M. Gossen) containing a Sleeping beauty (SB100) transposase gene. Two days after transfection, the cells were further cultivated in selection medium containing 7 μg/ml Puromycin (InvivoGen). Monoclonal cell lines were further generated by serial dilution in 96-well-plates. Clonal single-cell colonies were tested for expression efficiency using SDS-PAGE and western blot.
The obtained cell lines were grown to ∼90% confluency in T175 cell culture flasks (Sarstedt) under selection conditions for purification. Production medium (100 ml) containing only 2.5% fetal calf serum was added for 7 days and harvested by spinning down cell debris twice for 5 min at 500 g, followed by sterile filtration. The cell culture supernatant was concentrated to a final volume of 50 ml and purified on the AEKTA protein purification system using the HisTrap HP Ni-charged IMAC column (GE Healthcare) and subsequent size-exclusion chromatography using a Superdex 75 column (GE Healthcare) with PBS as the final solvent. The obtained fractions were pooled and concentrated by centrifugation in a Vivaspin 20 ultrafiltration unit (cutoff 10 kDa, Sartorius) for 20 min at 3300g and 4 °C. Purity was confirmed by SDS-PAGE and Coomassie stain.
+ Open protocol
+ Expand
8

AAV Production and Titration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant adeno-associated viruses were prepared as described previously (Burger and Nash, 2016 (link)). A mixture of plasmid DNAs including (1) AAV-DCX-Cre, pAdΔF6, and pAAV2/9, (2) AAV-CAG-DIO-EGFP, pAdΔF6, and pAAV2/9, or (3) AAV-CAG-DIO-mCherry, pAdΔF6, and pAAV2/9, was used to transfect AAVpro 293T cells (Takara Bio) seeded on twenty 15-cm dishes using polyethyleneimine “Max” (PEI-Max; Polysciences). After 2 d, cells were collected and lysed by three freeze–thaw treatments and lysates treated with Benzonase nuclease (Millipore). The rAAVs were purified from the lysates by ultracentrifugation using a discontinuous gradient of iodixanol (OptiPrep; Abbott Diagnostics Technologies AS). Banded rAAVs were collected from the 40% iodixanol layer, and the iodixanol buffer exchange to PBS and concentration of the rAAV was performed using a Vivaspin 20 ultrafiltration unit (100 kDa molecular weight cut off; Sartorius). For determination of the genomic titer, rAAVs were treated sequentially with DNaseI and Proteinase K, and the quantity of viral DNAs was determined by quantitative PCR using a StepOnePlus real-time PCR system (Applied Biosystems).
+ Open protocol
+ Expand
9

Recombinant Protein Purification from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effector or accessory protein expression construct was transformed into an E. coli T7 expression strain, NiCo21(DE3) (New England Biolabs) and grown as described in the Experimental Models and Subject Details section of the STAR methods. The cells were harvested by centrifugation and cell paste was resuspended in 80 ml of freshly prepared Lysis Buffer (50 mM Hepes pH 7.6, 0.5M NaCl, 10 mM imidazole, 14 mM 2-mercaptoethanol and 5% glycerol) supplemented with protease inhibitors (cOmplete, EDTA-free, Roche Diagnostics Corporation). The resuspended cells were broken by passing through a cell disruptor (Constant System Limited). Lysate was cleared by centrifugation twice at 28,000g for 30 min each. The clarified lysate was applied to a 5 ml HisTrap FF chromatography column (GE Life Sciences). Protein purification was performed via FPLC (AKTA Pure, GE Healthcare Life Sciences). After washing with Lysis Buffer, protein was eluted with a gradient of 10 mM to 250 mM of imidazole. Fractions containing protein of the expected size were pooled, concentrated in Vivaspin 20 ultrafiltration unit (Sartorius) and either used directly for biochemical assays or frozen at −80°C for storage. Protein purity was determined by SDS-PAGE analysis and protein concentration was determined by Qubit protein assay kit (Thermo Fisher).
+ Open protocol
+ Expand
10

Secretome Protein Enrichment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
To enrich the secretome proteins, the supernatants from control and treated PACs (10 ml each) were concentrated separately to 2 ml with a Vivaspin 20 Ultrafiltration Unit (Sartorius Göttingen, Germany). The resulting samples were then subjected to protein precipitation to reduce the volume and enrich the proteins. The precipitation was carried out by adding 3 volumes of ice-cold acetone containing 10% methanol and incubating overnight at −20°C. Precipitated proteins were pelleted by centrifugation at 12,000 g for 45 min at 4°C. The pellets were dried and resolved in urea buffer (30 mM Tris-HCl pH 8.5, 9.5 M urea, 2% CHAPS). The protein concentration was determined according to the Bradford method using BSA as the calibrator.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!